QQ客服 官方微博 反馈留言

	HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer
	Zhai, Yirui; Ma, Honglian; Hui, Zhouguang; Zhao, Lujun; Li, Dongming; Liang, Jun; Wang, Xiaozhen; Xu, Liming; Chen, Bo; Tang, Yu
	2019
卷号	131页码:27-34
关键词	Non-small cell lung cancer Endostar Concurrent chemoradiotherapy Anti-angiogenesis
ISSN号	0167-8140
DOI	10.1016/j.radonc.2018.10.032
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6344458
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Zhai, Yirui,Ma, Honglian,Hui, Zhouguang,et al. HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer[J],2019,131:27-34.
APA	Zhai, Yirui.,Ma, Honglian.,Hui, Zhouguang.,Zhao, Lujun.,Li, Dongming.,...&Wang, Luhua.(2019).HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer.,131,27-34.
MLA	Zhai, Yirui,et al."HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer".131(2019):27-34.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。